It's time to phase inRHDgenotyping for patients with a serologic weak D phenotype-Reference-Cited by-同舟云学术

It's time to phase inRHDgenotyping for patients with a serologic weak D phenotype

Published:2014-12-01 Issue:3 Volume:55 Page:680-689
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Sandler S. Gerald¹,Flegel Willy A.²^ORCID,Westhoff Connie M.³,Denomme Gregory A.⁴,Delaney Meghan⁵⁶,Keller Margaret A.⁷,Johnson Susan T.⁸,Katz Louis⁹,Queenan John T.¹⁰,Vassallo Ralph R.¹¹,Simon Clayton D.¹²

Affiliation:

1. Department of Pathology and Laboratory Medicine; MedStar Georgetown University Hospital; Washington DC

2. Department of Transfusion Medicine; Clinical Center; National Institutes of Health; Bethesda Maryland

3. Immunohematology and Genomics Laboratory; New York Blood Center; New York New York

4. Diagnostic Laboratories; BloodCenter of Wisconsin; Milwaukee Wisconsin

5. Red Cell Genomics Laboratory; Puget Blood Center; Seattle Washington

6. Department of Laboratory Medicine; University of Washington; Seattle Washington

7. National Molecular Laboratory; American Red Cross Biomedical Services; Philadelphia Pennsylvania

8. Clinical Education; BloodCenter of Wisconsin; Milwaukee Wisconsin

9. Medical Office; Americas Blood Centers; Washington DC

10. Department of Obstetrics and Gynecology; MedStar Georgetown University Hospital; Washington DC

11. Medical Office; American Red Cross Biomedical Services; Philadelphia Pennsylvania

12. Armed Services Blood Program; Falls Church Virginia

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12941/fullpdf

Reference149 articles.

1. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin/Results and recommendations related to supplemental questions in the comprehensive transfusion medicine survey of the College of American Pathologists;Sandler;Arch Pathol Lab Med,2014

2. Thirty-five years of Rh prophylaxis;Bowman;Transfusion,2003

3. An interaction between alleles at the Rh locus in man which weakens the reactivity of the Rh0 factor (Du);Ceppellini;Proc Natl Acad Sci U S A,1955

4. A new Rh allelomorph;Stratton;Nature,1946

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal red blood cell alloimmunization prevalence in the United States;Blood Advances;2024-08-15

2. Blood group genotype matching for transfusion;British Journal of Haematology;2024-08-05

3. Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee;Transfusion;2024-08

4. Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?;Transfusion and Apheresis Science;2024-08

5. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature;Immunohematology;2024-06-01